ÂÜÀòÂÒÂ×

Jamie Rich has a diverse work experience in the field of biotechnology and pharmaceutical research. Jamie is currently working at Zymeworks Inc. as the Director of Technology in ADC Therapeutic Development, a position they have held since March 2022. Prior to that, they worked at Zymeworks Inc. as the Associate Director of ADC Research from January 2020 to February 2022. Before joining Zymeworks, Jamie was a Principal Scientist from January 2018 to December 2019 and a Senior Scientist from March 2016 to December 2017 at the same company.

Jamie also worked as a Senior Scientist at Kairos Therapeutics in 2015 and as a Scientist at The Centre for Drug Research & Development (CDRD) from January 2013 to October 2015. Jamie began their career as an NSERC and MSFHR Postdoctoral Fellow at The University of British Columbia in 2007.

Overall, Jamie Rich has demonstrated expertise and progression in their career, holding positions of increasing responsibility and contributing to the advancement of biotechnology research and development.

Jamie Rich holds a Doctor of Philosophy (Ph.D.) degree in Organic Chemistry from the University of Alberta. No specific information regarding the start and end years of this educational experience is available.